The third issue of the CarDia newsletter has been published, bringing an up-to-date overview of new developments in the research of diabetes, obesity, and cardiovascular diseases:

Type 1 diabetes and sleep: A new study shows that patients with T1DM experience a more pronounced “social jetlag” and altered sleep patterns, which may affect glycemic control.

New UHF-ECG technology: The newly EU-certified ultra-high-frequency ECG significantly improves the precision of diagnosing and treating heart failure.

Fat and heart health: Research on epicardial fat reveals its paradoxical protective role in advanced stages of heart failure.

Modern obesity treatment: The CHEmic podcast highlights the potential of peptide-based therapies as well as the risks linked to new approaches in obesity treatment.

CarDia Meeting 2025: Experts reviewed the project’s results to date and discussed future directions and long-term funding for ongoing research.

‍